Today, Semler Scientific (NASDAQ: SMLR) shares reported an increase in net profits driven by unrealized profits from Bitcoin Holdings, rising above 2.64% to $35.37 after releasing its second quarter financial results for 2025.
Semler Scientific Reports 2Q2 2025 financial results, 5,021 BTC holdings and 31.3% YTD BTC yields. $ SMLR
– Joe Burnett, MSBA (@IIICAPITAL) August 4, 2025
The company recorded net profit of $606.9 million, up from just $11,000 in the same period last year. The increase fell to $8.2 million despite a 43% decline in revenue. Operating expenses rose to $10.3 million, resulting in a quarterly operating loss of $2.1 million. However, an unrealized profit of $83.8 million at Bitcoin Holdings has boosted pre-tax revenue to $80.6 million.
“We have made significant advances in Bitcoin’s financial strategy,” said Semler Scientific Eric Semler Executive Chairman. “From the beginning of the year until July 31, 2025, the strategy generated over $110 million in unrealized profits, resulting in a 31.3% BTC yield. We also appointed Natalie Brunell to the board and hired Joe Burnett as director of Bitcoin Strategy to help us to deepen our connection with the Bitcoin community.”
As of July 31, 2025, Semler reported that it held 5,021 Bitcoin at a fair value of $5,86.2 million, starting from 4,636 Bitcoin at the end of the second quarter. The company acquired approximately 1,829 Bitcoin in the quarter and July, spending a total of $195.4 million through operating cash flow, investment monetization and revenue from equity and debt provision.
“We were extremely pleased to launch Cardiovanta, a wholly owned subsidiary that drives future healthcare initiatives focused on early detection of heart failure and cardiac arrhythmia throughout the quarter.” “Cardiovanta believes it continues to be actively implemented in Bitcoin’s financial strategy, and therefore provides long-term value to our healthcare business.
In addition to the new subsidiary, Semler Scientific signed a new Market AT-Market (ATM) share offering agreement in April, allowing the company to issue and sell up to $500 million of common stock. As of July 31, it had raised approximately $194.3 million under the new contract.
“Semler Scientific has concluded new management shares offering sales agreements with Barclays Capital Inc., Cantor Fitzgerald & Co., Canaccord Genuity LLC, Needham & Company, LLC, Craig-Hallum Capital Group LLC, Lake Street Capital Markets, LLC and others.
If you are interested, please see the revenue for Semler Science Q2 2025 below for more information.
This post Semler Scientific Stock SMLR rises after Bitcoin gets fuel Q2 results first appeared in Bitcoin Magazine and are written by Oscar Zarraga Perez.
